Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

IMNM

Immunome, Inc.

Healthcare · USD

Set alert

Price alert · IMNM

All alert types
18.21 USD -0.08 -0.44%
As of Oct 30, 2026 Extended hours 18.88 +3.66%
Bid
18.22 × 1
Ask
18.24 × 2
17.82 Day range 18.98
15.24 52-week range 29.83
YTD
-15.22%
1 year
+13.95%
Open
18.25
Prev close
18.29
Mkt cap
2.15B
Vol
1.27M
Avg vol
1.28M
EPS
-2.52
P/E
0.00
Div yield
0.00%
More statistics
Low
17.82
High
18.98
Forward P/E
-7.41
Beta
2.56
Short ratio
10.98
Inst. own
102.76%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
22.64
200-d avg
22.51
1y target
35.33

5D chart

Chart tools
Interval
1m5m15m30m
IMNM five-day price chart17.517.918.418.919.3Oct 26Oct 27Oct 28Oct 30

Financial health

Altman Z-Score

29.46 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -8.8×
FY 2018: -1.9×FY 2019: -7.3×FY 2020: -5.7×FY 2021: -6.1×FY 2022: -0.7×FY 2023: -2.0×FY 2024: -2.1×FY 2025: -8.8×
FY 2018 5y median -2.1× FY 2025
P/S 270×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 15.1×FY 2024: 68.9×FY 2025: 270×
FY 2018 5y median 15.1× FY 2025
P/B 3.0×
FY 2018: -0.6×FY 2019: -2.2×FY 2020: 2.4×FY 2021: 3.1×FY 2022: 1.6×FY 2023: 1.8×FY 2024: 3.4×FY 2025: 3.0×
FY 2018 5y median 3.0× FY 2025
P/FCF -9.4×
FY 2018: -1.9×FY 2019: -7.9×FY 2020: -7.7×FY 2021: -8.2×FY 2022: -0.9×FY 2023: -25.3×FY 2024: -3.8×FY 2025: -9.4×
FY 2018 5y median -8.2× FY 2025
EV/EBITDA -5.9×
FY 2018: -2.0×FY 2019: -7.7×FY 2020: -3.4×FY 2021: -4.2×FY 2022: -0.2×FY 2023: -4.1×FY 2024: -3.2×FY 2025: -5.9×
FY 2018 5y median -4.1× FY 2025
EV/Sales 177×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 8.2×FY 2024: 53.6×FY 2025: 177×
FY 2018 5y median 8.2× FY 2025
FCF Yield -10.7%
FY 2018: -52.0%FY 2019: -12.7%FY 2020: -13.0%FY 2021: -12.2%FY 2022: -108.0%FY 2023: -4.0%FY 2024: -26.4%FY 2025: -10.7%
FY 2018 5y median -12.2% FY 2025

Profitability

Gross Margin 57.4%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 57.4%
FY 2018 5y median 57.4% FY 2025
Operating Margin -3084.8%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -781.4%FY 2024: -3382.4%FY 2025: -3084.8%
FY 2018 5y median -781.4% FY 2025
Net Margin -3060.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -761.9%FY 2024: -3240.4%FY 2025: -3060.0%
FY 2018 5y median -761.9% FY 2025
ROE -33.5%
FY 2018: 31.1%FY 2019: 29.6%FY 2020: -43.1%FY 2021: -51.3%FY 2022: -221.6%FY 2023: -89.1%FY 2024: -161.7%FY 2025: -33.5%
FY 2018 5y median -89.1% FY 2025
ROIC -33.5%
FY 2018: -221.3%FY 2019: -269.1%FY 2020: -29.2%FY 2021: -52.0%FY 2022: -217.8%FY 2023: -86.2%FY 2024: -164.4%FY 2025: -33.5%
FY 2018 5y median -86.2% FY 2025
ROA -31.1%
FY 2018: -176.4%FY 2019: -208.5%FY 2020: -40.1%FY 2021: -42.7%FY 2022: -153.4%FY 2023: -71.9%FY 2024: -121.9%FY 2025: -31.1%
FY 2018 5y median -71.9% FY 2025

Growth (YoY)

Revenue -23.2%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -35.5%FY 2025: -23.2%
FY 2018 FY 2025
Operating Income 30.0%
FY 2018: 0.0%FY 2019: -33.6%FY 2020: -18.5%FY 2021: -105.6%FY 2022: -46.4%FY 2023: -196.8%FY 2024: -179.2%FY 2025: 30.0%
FY 2018 FY 2025
EPS (diluted) 51.4%
FY 2018: 0.0%FY 2019: 74.4%FY 2020: 8.2%FY 2021: -26.6%FY 2022: -44.4%FY 2023: -74.1%FY 2024: 7.1%FY 2025: 51.4%
FY 2018 FY 2025
Free Cash Flow -22.1%
FY 2018: 0.0%FY 2019: -28.8%FY 2020: -29.4%FY 2021: -43.9%FY 2022: -58.1%FY 2023: 71.0%FY 2024: -1856.2%FY 2025: -22.1%
FY 2018 FY 2025

Financial Health

Current Ratio 14.7×
FY 2018: 1.4×FY 2019: 1.9×FY 2020: 14.1×FY 2021: 5.8×FY 2022: 3.1×FY 2023: 6.6×FY 2024: 4.1×FY 2025: 14.7×
FY 2018 5y median 5.8× FY 2025
Quick Ratio 14.7×
FY 2018: 1.4×FY 2019: 1.9×FY 2020: 14.1×FY 2021: 5.8×FY 2022: 3.1×FY 2023: 6.6×FY 2024: 4.1×FY 2025: 14.7×
FY 2018 5y median 5.8× FY 2025
Debt / Equity 0.0×
FY 2018: -0.0×FY 2019: -0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 3.1×
FY 2018: 0.1×FY 2019: 0.2×FY 2020: 2.3×FY 2021: 2.0×FY 2022: 0.6×FY 2023: 3.5×FY 2024: 0.9×FY 2025: 3.1×
FY 2018 5y median 2.0× FY 2025
Interest Coverage 0.0×
FY 2018: -54.9×FY 2019: -97.6×FY 2020: -323×FY 2021: -2520×FY 2022: -7380×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31